The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evolution and clinical impact of genomic alterations detectable in circulating tumor DNA of 1150 advanced EGFR-mutant (mt) lung cancer patients.
 
Collin M. Blakely
Research Funding - Clovis Oncology (Inst); Ignyta (Inst); MedImmune (Inst); Mirati Therapeutics (Inst)
 
Wei Wu
No Relationships to Disclose
 
Matthew A. Gubens
Consulting or Advisory Role - ARIAD; Boehringer Ingelheim; Bristol-Myers Squibb; Calithera Biosciences; Clovis Oncology; Nektar; Pfizer
Research Funding - Abbvie (Inst); Celgene (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); OncoMed (Inst)
Travel, Accommodations, Expenses - Celgene; Genentech/Roche
 
Julia Rotow
No Relationships to Disclose
 
Victoria Wang
Stock and Other Ownership Interests - Abbott; Abbvie; Amgen; Blueprint Genetics; Gilead Sciences (I); Kura Oncology; Sunesis Pharmaceuticals
 
Kimberly Banks
Employment - Guardant Health
 
Richard B. Lanman
Employment - Guardant Health; Veracyte
Leadership - Guardant Health
Stock and Other Ownership Interests - Guardant Health; Veracyte
Research Funding - Guardant Health
 
Philip C. Mack
Honoraria - Guardant Health
Consulting or Advisory Role - Apton Biosystems; AstraZeneca; MolecularMD; Novartis
Research Funding - Boehringer Ingelheim
Travel, Accommodations, Expenses - Guardant Health
 
Hatim Husain
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Bristol-Myers Squibb
 
Caroline Elizabeth McCoach
Honoraria - ARIAD
 
Robert Charles Doebele
Honoraria - AstraZeneca; Clovis Oncology; Loxo; OxOnc; Pfizer
Consulting or Advisory Role - Array BioPharma; Lilly; Loxo; OxOnc; Pfizer; Pfizer
Research Funding - Abbott Molecular; Loxo; Mirati Therapeutics
Patents, Royalties, Other Intellectual Property - Licensing Fees for Biologic Material from Ariad (Inst); Licensing Fees for Biologic Material from Blueprint Medicines (Inst); Licensing Fees for Biologic Material from Chugai (Inst); Licensing Fees for Biologic Materials from GVKbio; Licensing Fees for Biologic Materials from Loxo Oncology (Inst); Licensing Fees from Abbott Molecular for Patent PCT/US2013/057495
Travel, Accommodations, Expenses - Ignyta
 
Jonathan Riess
Honoraria - Roche/Genentech
Consulting or Advisory Role - ARIAD; Celgene; Clovis Oncology; Medtronic
Research Funding - Merck (Inst); Millennium (Inst); Novartis (Inst); Onconova Therapeutics
Travel, Accommodations, Expenses - Celgene; Roche/Genentech
 
Trever Grant Bivona
Employment - Plexxikon (I)
Consulting or Advisory Role - ARIAD; Array BioPharma; AstraZeneca; Novartis; Revolution Health Care
Research Funding - Ignyta; Revolution Health Care